The Individual Therapy for Patients With Wilson's Disease

NCT03957720 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Wilson's Disease

Interventions

DRUG: DMPS
DRUG: Penicillamine
DRUG: DMSA
DRUG: Zinc gluconate

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University